U.K. Market Overview of Cough, Cold, Flu and Allergy Remedies - May 2017

It is important to note that cough, cold and flu are caused by various factors, and if left untreated may affect the respiratory tract. To further elaborate this segment, Market Research Hub (MRH) has recently added a report titled as “Cough, Cold, Flu and Allergy Remedies- U.K. - May 2017” to its vast database of research reports. This research study focuses on the cough, cold, flu, and allergy remedies concerned with the UK market, with detailed descriptive awareness to young adults so they seek out the correct treatment for the respective needs.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1069403

Cold and flu are caused by different viruses but allergies are not virus borne, instead, it is a medical problem related to the body’s immune system that reacts towards an allergen. These problems individually may further introduce different problems in the patient’s body if left untreated for long, so a remedy is always advisable. Firstly, the report covers the detailed overview of cough, cold, flu and allergy remedies, products covered & excluded and the category which benefit from the provided healthy growth. The research has also analyzed best and worst case forecast of the U.K’s value sales of the cough, cold and flu relief, medicated confectionery, and allergy remedies for the time period during 2011-21. The report also highlights the issues and insights of the market, the market growth factors, market size & forecast and finally market segmentation of cough, cold, flu & allergy remedy done for the year 2015 and 2016.

In the next section, the market drivers are elaborated and detailed that include the aging population, Flu jab extension, unemployment, dietary boost, and the allergies that are continuously on the rise. The market share of the main companies is also studied and provided in the research study which shows Lemsip retains market for cold and flu remedies, Night Nurse and Day & Night Nurse outperform the broader market, Covonia extends market share of cough liquids, Strepsils still a go-to for medicated confectionery, Jakemans benefiting from a distinctive positioning, and lack of strong players in allergy remedies benefits own-label.

In the concluding section, the research provides details regarding the launch activity and innovation on the remedy market. Some of the activities and innovations discussed in the report are; Own-label brings innovation back (that shows the new product development in the cough, cold, flu, and allergy remedies market), Market lacks an NPD leader, along with Drug-driving laws which could affect NPD (New Project Development). The advertising and marketing activity is also included in the report that describes the investment, out-of-season approach, and the ad campaigns by GSK, Sudafed, and Nielson. This report ends with the barriers and behaviors towards the cold & flu remedies followed by experience, treatment, behavior & attitude towards allergies and its remedies.

Browse Full Report With TOC: http://www.marketresearchhub.com/report/cough-cold-flu-and-allergy-remedies-uk-may-2017-report.html

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News: https://www.industrynewsanalysis.com/

This release was published on openPR.